HomeCompareEURN vs MRK

EURN vs MRK: Dividend Comparison 2026

EURN yields 41.94% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EURN wins by $22292418113.74M in total portfolio value
10 years
EURN
EURN
● Live price
41.94%
Share price
$16.74
Annual div
$7.02
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22292418113.80M
Annual income
$22,190,763,194,327,570.00
Full EURN calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — EURN vs MRK

📍 EURN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEURNMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EURN + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EURN pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EURN
Annual income on $10K today (after 15% tax)
$3,564.52/yr
After 10yr DRIP, annual income (after tax)
$18,862,148,715,178,430.00/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, EURN beats the other by $18,862,148,715,169,836.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EURN + MRK for your $10,000?

EURN: 50%MRK: 50%
100% MRK50/50100% EURN
Portfolio after 10yr
$11146209056.93M
Annual income
$11,095,381,597,168,840.00/yr
Blended yield
99.54%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

EURN
Analyst Ratings
9
Buy
10
Hold
Consensus: Hold
Price Target
$21.00
+25.4% upside vs current
Range: $21.00 — $21.00
Altman Z
1.8
Piotroski
4/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EURN buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEURNMRK
Forward yield41.94%2.81%
Annual dividend / share$7.02$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$22292418113.80M$57.7K
Annual income after 10y$22,190,763,194,327,570.00$10,113.78
Total dividends collected$22285714226.36M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$21.00$128.54

Year-by-year: EURN vs MRK ($10,000, DRIP)

YearEURN PortfolioEURN Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$19,087$8,387.10$11,213$373.04+$7.9KEURN
2$50,346$29,922.49$12,667$512.06+$37.7KEURN
3$201,395$147,525.24$14,439$708.14+$187.0KEURN
4$1,318,553$1,103,060.33$16,640$988.16+$1.30MEURN
5$14,909,621$13,498,768.67$19,432$1,394.07+$14.89MEURN
6$301,258,262$285,304,967.64$23,057$1,992.90+$301.24MEURN
7$11,097,610,544$10,775,264,204.50$27,889$2,894.79+$11097.58MEURN
8$753,807,394,625$741,932,951,342.99$34,518$4,286.29+$753807.36MEURN
9$95,004,597,639,920$94,198,023,727,670.70$43,912$6,494.35+$95004597.60MEURN
10$22,292,418,113,802,280$22,190,763,194,327,570.00$57,714$10,113.78+$22292418113.74MEURN

EURN vs MRK: Complete Analysis 2026

EURNStock

Euronav NV, together with its subsidiaries, engages in the transportation and storage of crude oil worldwide. The company also offers floating, storage, and offloading (FSO) services. As of April 1, 2022, it owned and operated a fleet of 72 vessels, including 6 chartered-in vessels with an aggregate carrying capacity of approximately 18.5 million deadweight tons consisting of 41 very large crude carriers, 2 V-plus, 27 Suezmax vessels, and 2 FSO vessels. The company was incorporated in 2003 and is headquartered in Antwerp, Belgium.

Full EURN Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this EURN vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EURN vs SCHDEURN vs JEPIEURN vs OEURN vs KOEURN vs MAINEURN vs JNJEURN vs ABBVEURN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.